Assembly Biosciences

Assembly Biosciences(ASMB)

SOUTH SAN FRANCISCO, CA
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Small Molecule Antivirals

Assembly Biosciences is a life sciences company focused on Small Molecule Antivirals.

Infectious DiseasesNeurology
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
2

Pipeline & Clinical Trials

Video-based Task-specific Training
Stroke
N/A
Clinical Trials (1)
NCT07208422Task-Specific Self-Rehabilitation Training (TASSRET) Trial
N/A
Quality Improvement
Type 2 Diabetes Mellitus
N/A
Phase 1
Clinical Trials (1)
NCT03923478ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
Phase 1
Phase 1
Clinical Trials (1)
NCT02908191A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
Phase 1
Phase 1
Clinical Trials (1)
NCT06384131A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
Phase 1
Phase 1
Clinical Trials (1)
NCT06740474A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants
Phase 1
Phase 1
Clinical Trials (1)
NCT04637139A Study to Evaluate the Mass Balance Absorption and AME of VBR
Phase 1
Phase 1
Clinical Trials (1)
NCT05414981A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection
Phase 1
ABI-4334 Tablet
Chronic Hepatitis B
Phase 1
Clinical Trials (1)
NCT05569941A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects
Phase 1
ABI-H3733 Liquid Oral Dosage Form
Chronic Hepatitis B
Phase 1
Clinical Trials (1)
NCT04271592A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults
Phase 1
Phase 1
Clinical Trials (1)
NCT06385327A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes
Phase 1
Phase 1
Clinical Trials (1)
NCT03714152A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B
Phase 1
ABI-H2158 Reference Formulation
Chronic Hepatitis B
Phase 1
Clinical Trials (1)
NCT04083716A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults
Phase 1
Phase 1
Clinical Trials (1)
NCT04142762A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults
Phase 1
Phase 1
Clinical Trials (1)
NCT06698575A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes
Phase 1
Phase 1/2
Clinical Trials (1)
NCT03109730Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B
Phase 1/2
Phase 2
Clinical Trials (1)
NCT04454567A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors
Phase 2
Phase 2
Clinical Trials (1)
NCT03577171A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
Phase 2
Phase 2
Clinical Trials (1)
NCT04781647A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection
Phase 2
standard of care
Chronic Hepatitis B
Phase 2
Clinical Trials (1)
NCT03780543A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Phase 2
Phase 2
Clinical Trials (1)
NCT03576066A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection
Phase 2
Phase 2
Clinical Trials (1)
NCT04398134A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection
Phase 2
Phase 2
Clinical Trials (1)
NCT04820686A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection
Phase 2

Open Jobs (2)

Medical Writing Contractor

Regulatory Affairs
1w ago

Regulatory Affairs Associate II Contractor

Regulatory Affairs
1w ago
Interview Prep Quick Facts
Founded: 2012
Portfolio: 22 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 2 active jobs

Financials (FY2024)

Revenue
$7M
R&D Spend
$49M(683%)30%
Net Income
-$61M
Cash
$20M
Source: SEC 10-K Filing

Hiring Trend

Stable
2
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub